Identification and characterization of a new base substitution in the vaccine strain of Sabin 3 poliovirus.
The complete RNA sequence of Sabin 3 (LED3) used in vaccine in the United States has been determined. The LED3 Sabin 3 sequence contains the attenuating mutations at bases 472 and 2034 but differs from that published by Stanway et al. (Nucleic Acids Res., 11, 5629-5643, 1983) at two other base positions, 2493 and 6061. The change at base 6061 is silent and does not affect amino acid composition. The other base, a C at position 2493, is contained in the viral capsid protein VP1 and predicts a new Sabin 3 specific amino acid change of a threonine instead of an isoleucine at amino acid 6 of the protein [corrected]. Reversion of this base to that present in the pathogenic progenitor strain, Leon, is observed to occur after replication of vaccine virus in the gut of primary vaccines and in nervous tissue of neurovirulence test monkeys. Passage conditions have been identified that lead to the reversion of base 2493 as well as the reversion of the attenuated base to the parental base (Leon) at position 472 in the 5' noncoding region. The observation that these two bases delta position are found to revert during passage suggests that there is a selective advantage for virus containing the parental bases at these positions.
Weeks-Levy
C
C
Lederle-Praxis Biologicals, Pearl River, New York 10965.
Tatem
J M
JM
DiMichele
S J
SJ
Waterfield
W
W
Georgiu
A F
AF
Mento
S J
SJ
D000818:Animals; D002213:Capsid / Q000235:genetics*; D036022:Capsid Proteins; D014644:Genetic Variation / Q000235:genetics; D000882:Haplorhini / Q000382:microbiology; D009154:Mutation / Q000235:genetics; D017955:Poliovirus / Q000235:genetics* / Q000472:pathogenicity; D011055:Poliovirus Vaccine, Oral; D012641:Selection, Genetic; D014774:Virulence / Q000235:genetics
D036022:Capsid Proteins; D011055:Poliovirus Vaccine, Oral; C442540:VP1 protein, Poliovirus